A Cell-Based Screen For The Discovery of Novel Proteolysis Targeting Chimeras (PROTACs)

NIH RePORTER · NIH · R21 · $237,500 · view on reporter.nih.gov ↗

Abstract

Project Summary Proteolysis targeting chimeras (PROTACs) represent an exciting new modality to inhibit proteins. These reagents are chemical dimerizers that recruit an E3 ubiquitin ligase to a target protein of interest, resulting in poly- ubiquitylation of the target protein and its subsequent degradation by the proteasome. Recently, it has become clear that the E3 ligase must make productive contacts with the substrate. In other words, not all target proteins can be turned over by a single E3 Ub ligase. This project will develop a cell-based screen for degradation of a GFP-target protein fusion that employs a known ligand for the target protein fused to a complex library of potential E3 ligase ligands, thus allowing the cell to “tell us” which of the ≈ 500 E3 Ub ligases in the cell are best suited for targeting that protein for destruction.

Key facts

NIH application ID
9842656
Project number
5R21GM131420-02
Recipient
SCRIPPS FLORIDA
Principal Investigator
Thomas J. Kodadek
Activity code
R21
Funding institute
NIH
Fiscal year
2020
Award amount
$237,500
Award type
5
Project period
2019-01-01 → 2021-03-31